2016Pharmacy managementRequires access

Drug choices reviewed for benign prostatic hyperplasia : review

Lisa Selwood

Open publisher page 0 citations

Abstract

Benign prostatic hyperplasia (BPH) is a common condition affecting men aged ≥ 40 years, and the incidence increases with age. The association between BPH and lower urinary tract symptoms (LUTS) is well elucidated. This review will focus on treatment options for BPH.

About this research paper

What this paper is about

Benign prostatic hyperplasia (BPH) is a common condition affecting men aged ≥ 40 years, and the incidence increases with age. The association between BPH and lower urinary tract symptoms (LUTS) is well elucidated. This review will focus on treatment options for BPH.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Benign prostatic hyperplasia (BPH) is a common condition affecting men aged ≥ 40 years, and the incidence increases with age. The association between BPH and lower urinary tract symptoms (LUTS) is well elucidated. This review will focus on treatment options for BPH.

Key concepts: Medicine, Lower urinary tract symptoms, Hyperplasia, Urology, Incidence (geometry), Drug, Prostate, Urinary system

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug choices reviewed for benign prostatic hyperplasia : review — Research Paper | ScholarLens